MetaCap

Allarity Therapeutics (ALLR) vs MIRA Pharmaceuticals (MIRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Allarity Therapeutics (ALLR) has outperformed MIRA Pharmaceuticals (MIRA) over the past year, losing 25.9% versus a loss of 79.1%. Allarity Therapeutics is the larger company by market cap ($12.6 million vs $12.2 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ALLR-25.94%MIRA-79.06%
+74%-6%-86%
Nov 21, 20251 yearNov 20, 2026
ALLR-99.94%MIRA-95.16%
+19%-43%-106%
Jul 31, 20235 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ALLR versus MIRA key metrics
MetricALLRMIRA
Share price$0.785$0.291
Market cap$12.56M$12.23M
1-day change-9.25%-20.84%
YTD return-27.31%-80.73%
1-year return-25.94%-79.06%
P/E ratio (TTM)—29.10
EPS (TTM)$-0.79$0.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$320.00K—
Net income (latest FY)$-11.23M$-10.44M
Operating margin-3939.06%—
Net margin-3509.69%—
52-week high$1.84$1.69
52-week low$0.769$0.255
Distance from 52-week high-57.34%-82.78%
Analyst consensusnonenone
Avg. price target upside+1301.27%+1102.75%
Average volume131.74K622.02K
Shares outstanding16.00M42.02M
Employees7—
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ALLR has outperformed MIRA by 53.1 percentage points over the past year.

About Allarity Therapeutics

ALLR stock →

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology.

Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees

About MIRA Pharmaceuticals

MIRA stock →

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.

Health Care · Biotechnology: Pharmaceutical Preparations

ALLR vs MIRA FAQ

Which is bigger, Allarity Therapeutics or MIRA Pharmaceuticals?

Allarity Therapeutics (ALLR) is larger, with a market capitalization of $12.56M compared with $12.23M for MIRA Pharmaceuticals (MIRA).

Which stock has performed better over the past year, ALLR or MIRA?

ALLR returned -25.94% over the past 12 months, compared with -79.06% for MIRA (price return, excluding dividends). Past performance does not predict future results.

Are Allarity Therapeutics and MIRA Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons